Growth Metrics

Cytek Biosciences (CTKB) Retained Earnings (2020 - 2025)

Historic Retained Earnings for Cytek Biosciences (CTKB) over the last 6 years, with Q3 2025 value amounting to -$57.7 million.

  • Cytek Biosciences' Retained Earnings fell 2859.5% to -$57.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$57.7 million, marking a year-over-year decrease of 2859.5%. This contributed to the annual value of -$35.2 million for FY2024, which is 2063.54% down from last year.
  • Per Cytek Biosciences' latest filing, its Retained Earnings stood at -$57.7 million for Q3 2025, which was down 2859.5% from -$52.2 million recorded in Q2 2025.
  • In the past 5 years, Cytek Biosciences' Retained Earnings ranged from a high of -$17.0 million in Q4 2022 and a low of -$57.7 million during Q3 2025
  • In the last 5 years, Cytek Biosciences' Retained Earnings had a median value of -$28.7 million in 2023 and averaged -$31.8 million.
  • As far as peak fluctuations go, Cytek Biosciences' Retained Earnings skyrocketed by 1327.46% in 2021, and later tumbled by 7133.29% in 2023.
  • Quarter analysis of 5 years shows Cytek Biosciences' Retained Earnings stood at -$19.6 million in 2021, then rose by 13.14% to -$17.0 million in 2022, then tumbled by 71.33% to -$29.2 million in 2023, then fell by 20.64% to -$35.2 million in 2024, then crashed by 63.82% to -$57.7 million in 2025.
  • Its Retained Earnings stands at -$57.7 million for Q3 2025, versus -$52.2 million for Q2 2025 and -$46.6 million for Q1 2025.